Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gallo P, Chuang-Stein C, Dragaiin V, Gaydos B, Krams M, Pinheiro J. Executive summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development. J Biopharm Stat. 2006;16:275–283.
Quinlan JA, Krams M. Implementing adaptive designs: logistical and operational considerations. Drug Inf J. 2006;40:437–444.
Gaydos B, Krams M, Perevozskaya I, et al. Adaptive dose response studies. Drug Inf J. 2006; 40:451–461.
Bornkamp B, Bretz F, Dmitrienko A, et al. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat. 2007;17:965–995. Available at: https://doi.org/biopharmnet.com/doc/doc12005.html.
Maca J, Bhattacharya S, Dragalin V, Gallo P, Krams M. Adaptive seamless phase II/III designs—background, operational aspects, and examples. Drug Inf J. 2006;4:463–473.
Gould AL, Shih WJ. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Comm Stat. 1992;(A)21:2833–2853.
Sandvik L, Erikssen J, Mowinckel P, Rodland EA. A method for determining the size of internal pilot studies. Stat Med. 1996;15:1587–1590.
Chuang-Stein C, Anderson K, Gallo P, Collins S. Sample size reestimation: a review and recommendations. Drug Inf J. 2006;40:475–484.
Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo J-M, Ford GA. Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose response study of UK-279,276 in acute ischemic stroke. Stroke. 2003;34:2543–2548.
Berry DA, Müller P, Grieve AP, et al. Adaptive Bayesian designs for dose-ranging drug trials. In Gatsonis C, Carlin B, Carriquiry A, eds., Case Studies in Bayesian Statistics V:99–181. New York: Springer-Verlag; 2001.
Gallo P, Chuang-Stein C. What should be the role of homogeneity testing in adaptive trials? Pharm Stat. 2009;8:1–4.
Posch M, Koenig F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Stat Med. 2005; 24:3697–3714.
Brannath W, König F, Bauer P. Estimation in flexible two-stage designs. Stat Med. 2005;25: 3366–3381.